Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Lycanbull Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1825866616254480384.png) Lycanbull [@Lycanbull](/creator/twitter/Lycanbull) on x 5189 followers
Created: 2025-07-14 13:30:24 UTC

$GILD Gilead Presents New Data on Twice-Yearly Lenacapavir (Yeztugo®) for HIV Prevention at IAS 2025


![](https://pbs.twimg.com/card_img/1943119607067246592/sUyDtA1g?format=png&name=600x314)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1944751332788785557/c:line.svg)

**Related Topics**
[$gild](/topic/$gild)
[gilead sciences](/topic/gilead-sciences)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/Lycanbull/status/1944751332788785557)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Lycanbull Avatar Lycanbull @Lycanbull on x 5189 followers Created: 2025-07-14 13:30:24 UTC

$GILD Gilead Presents New Data on Twice-Yearly Lenacapavir (Yeztugo®) for HIV Prevention at IAS 2025

XXX engagements

Engagements Line Chart

Related Topics $gild gilead sciences stocks healthcare

Post Link

post/tweet::1944751332788785557
/post/tweet::1944751332788785557